RIVAROXABAN (Xarelto)

Clinical Indication

Primary thromboprophylaxis in children over 2 years and adults with a Fontan circulation

Date of classification

July 2025

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.